Can Ganciclovir be Replaced with Valganciclovir as a Preemptive Therapy for Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantu (HSCT) Recipients?

被引：0
|
作者：
Sachdev, M. [1 ]
Chakraborty, S. [1 ]
Bansal, M. [1 ]
Dua, V. [1 ]
机构：
[1] Fortis Mem Res Inst, Pediat Hematol Oncol Bmt, Gurugram, India
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O0149
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [21] Oral valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic stem cell transplantation recipients
    Michael, M.
    Kourti, G.
    Bouzani, M.
    Grispou, O.
    Anagnostopoulou, M.
    Baltathakis, I.
    Apostolidis, I.
    Karakasis, D.
    Harhalakis, N.
    Paniara, O.
    Nikiforakis, E.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S285 - S286
  • [22] Oral valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic stem cell transplantation recipients
    Pastore, D.
    Carluccio, P.
    Gaudio, F.
    Perrone, T.
    Delia, M.
    Albano, F.
    Manduzio, P.
    Fesce, V.
    Mongelli, P.
    Liso, V.
    Specchia, G.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S266 - S267
  • [23] Preemptive Therapy for Cytomegalovirus Disease in Allogeneic Stem Cell Transplant Recipients
    de la Cruz-Vicente, F.
    Cerezuela Martinez, P.
    Gil-Esparraga, E.
    Martin Aguilera, C.
    Aguilar Guisado, M.
    Parody Ruiz-Berdejo, R.
    Cisneros Herreros, J. M.
    Urbano-Ispizua, A.
    Espigado Tocino, I.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (09) : 3102 - 3103
  • [24] Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients
    Kiehl, MG
    Basara, N
    BLOOD, 2001, 98 (05) : 1626 - 1626
  • [25] Fusarium infection in hematopoietic stem cell transplant (HSCT) recipients.
    Nucci, M
    Marr, KA
    Queiroz-Telles, F
    Martins, CA
    Trabasso, P
    Costa, S
    Voltarelli, JC
    Colombo, AL
    Carter, RA
    Pasquini, R
    De Souza, C
    Anaissie, EJ
    BLOOD, 2002, 100 (11) : 440B - 440B
  • [26] Cytomegalovirus in hematopoietic stem cell transplant recipients - management of infection
    Locatelli, Franco
    Bertaina, Alice
    Bertaina, Valentina
    Merli, Pietro
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (11) : 1093 - 1105
  • [27] Prevention of Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation: Preemptive Therapy Vs Universal Prophylaxis
    Mossad, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E329 - E329
  • [28] Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation
    Reusser, P
    Einsele, H
    Lee, J
    Volin, L
    Rovira, M
    Engelhard, D
    Finke, J
    Cordonnier, C
    Link, H
    Ljungman, P
    BLOOD, 2002, 99 (04) : 1159 - 1164
  • [29] Prophylactic Acyclovir and Preemptive Ganciclovir To Prevent Cytomegalovirus Disease in Children After Hematopoietic Stem Cell Transplant
    Tavil, Betul
    Azik, Fatih Mehmet
    Bozkaya, Ikbal
    Gokcebay, Dilek Gurlek
    Tezer, Hasan
    Tunc, Bahattin
    Uckan, Duygu
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2014, 12 (05) : 462 - 468
  • [30] Ganciclovir treatment failure in adult allogeneic hematopoietic stem cell transplant recipients with cytomegalovirus infection - a single centre experience
    Vejrazkova, E.
    Hubacek, P.
    Kutova, R.
    Pliskova, L.
    Kostal, M.
    Stepanova, V
    Zavrelova, A.
    Radocha, J.
    Mala, E.
    Zak, P.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2015, 64 (03): : 160 - 168
12345